NDM-1- and OXA-23-producing Acinetobacter baumannii isolated from intensive care unit patients in Tunisia

•High prevalence of imported/acquired carbapenem-resistant A. baumannii (CRAB) faecal carriage among ICU patients.•OXA-23 was the most frequent carbapenemase among identified CRAB, followed by NDM-1.•Co-occurrence of carbapenem and aminoglycoside resistance genes among multidrug-resistant A. baumann...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of antimicrobial agents 2018-12, Vol.52 (6), p.910-915
Hauptverfasser: Maamar, Elaa, Alonso, Carla Andrea, Ferjani, Sana, Jendoubi, Ali, Hamzaoui, Zaineb, Jebri, Alia, Saidani, Mabrouka, Ghedira, Salma, Torres, Carmen, Boubaker, Ilhem Boutiba-Ben
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 915
container_issue 6
container_start_page 910
container_title International journal of antimicrobial agents
container_volume 52
creator Maamar, Elaa
Alonso, Carla Andrea
Ferjani, Sana
Jendoubi, Ali
Hamzaoui, Zaineb
Jebri, Alia
Saidani, Mabrouka
Ghedira, Salma
Torres, Carmen
Boubaker, Ilhem Boutiba-Ben
description •High prevalence of imported/acquired carbapenem-resistant A. baumannii (CRAB) faecal carriage among ICU patients.•OXA-23 was the most frequent carbapenemase among identified CRAB, followed by NDM-1.•Co-occurrence of carbapenem and aminoglycoside resistance genes among multidrug-resistant A. baumannii.•Circulation of clonally related CRAB strains. Gastrointestinal colonisation by carbapenem-resistant Acinetobacter baumannii (CRAB) is a critical step before nosocomial infection. This study evaluated CRAB intestinal carriage in patients admitted to a Tunisian ICU and determined the antimicrobial resistance mechanisms involved. From December 2014 to February 2015, all 63 patients admitted to the ICU were screened for rectal CRAB colonisation upon admission and once weekly thereafter. ICU patients who acquired a CRAB nosocomial infection were also included. β-Lactamases and associated resistance genes were screened by PCR sequencing, and molecular typing was performed by PFGE and MLST. The CRAB faecal carriage rate at admission was 4.8% (3/63). The CRAB acquisition rate during ICU stay was analysed in 39 of the remaining 60 patients and the rate of acquired CRAB faecal carriage was 15.4% (6/39); 4 patients also showed an ICU-acquired CRAB infection (one patient was a faecal carrier and suffered infection). Overall, 13 CRAB isolates were collected from 12 patients, of which 11 isolates showed resistance to all antibiotics tested except colistin. blaOXA-23 and blaNDM-1 were detected in 11 and 2 isolates, respectively. All OXA-23-producing strains carried armA, tetB, sul1 and catB, and some of them carried aph(3′)-VIa, blaTEM-1, aph(3′)-Ia and ant(2′′)-Ia. The blaNDM-1-positive isolates harboured aph(3′)-VIa and catB. Three PFGE patterns and two STs were identified [ST195 (n = 11), ST1089 (n = 2, NDM-1-positive)]. Whether imported or acquired during ICU stay, CRAB colonisation is a major risk factor for the occurrence of serious nosocomial infection. Systematic screening of faecal carriage is mandatory to prevent their spread.
doi_str_mv 10.1016/j.ijantimicag.2018.04.008
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2027070688</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0924857918301109</els_id><sourcerecordid>2027070688</sourcerecordid><originalsourceid>FETCH-LOGICAL-c377t-252c9c3e3517fc502c0d0c37fa201d2e0b56b144dfbbaafa3f1949ffc1efb68c3</originalsourceid><addsrcrecordid>eNqNkE9vFDEMxSNERbeFr4DCjUsGJ5P5d1wttFQq7aVI3KJMxqm82sksSaYS355UWxBHLrZkP_vp_Rj7IKGSINtP-4r2NmSaydnHSoHsK9AVQP-KbWTfKdENsn7NNjAoLfqmG87ZRUp7ANnUunnDztXQto3WesPo7vM3IQW3YeL3P7ZC1eIYl2l1FB75tlTMy2hdxshHu842BCJOaTnYjBP3cZk5hYwh0RNyZyPyNVDmR5sJQ05lyR_KJJF9y868PSR899Iv2ferLw-7r-L2_vpmt70Vru66LFSj3OBqrBvZedeAcjBBWXlbck4KYWzaUWo9-XG01tvay0EP3juJfmx7V1-yj6e_JcfPFVM2MyWHh4MNuKzJKFAddND2fZEOJ6mLS0oRvTlGmm38ZSSYZ9Jmb_4hbZ5JG9CmkC63719s1nHG6e_lH7RFsDsJsIR9IowmucLE4UQRXTbTQv9h8xuwN5Zc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2027070688</pqid></control><display><type>article</type><title>NDM-1- and OXA-23-producing Acinetobacter baumannii isolated from intensive care unit patients in Tunisia</title><source>Elsevier ScienceDirect Journals</source><creator>Maamar, Elaa ; Alonso, Carla Andrea ; Ferjani, Sana ; Jendoubi, Ali ; Hamzaoui, Zaineb ; Jebri, Alia ; Saidani, Mabrouka ; Ghedira, Salma ; Torres, Carmen ; Boubaker, Ilhem Boutiba-Ben</creator><creatorcontrib>Maamar, Elaa ; Alonso, Carla Andrea ; Ferjani, Sana ; Jendoubi, Ali ; Hamzaoui, Zaineb ; Jebri, Alia ; Saidani, Mabrouka ; Ghedira, Salma ; Torres, Carmen ; Boubaker, Ilhem Boutiba-Ben</creatorcontrib><description>•High prevalence of imported/acquired carbapenem-resistant A. baumannii (CRAB) faecal carriage among ICU patients.•OXA-23 was the most frequent carbapenemase among identified CRAB, followed by NDM-1.•Co-occurrence of carbapenem and aminoglycoside resistance genes among multidrug-resistant A. baumannii.•Circulation of clonally related CRAB strains. Gastrointestinal colonisation by carbapenem-resistant Acinetobacter baumannii (CRAB) is a critical step before nosocomial infection. This study evaluated CRAB intestinal carriage in patients admitted to a Tunisian ICU and determined the antimicrobial resistance mechanisms involved. From December 2014 to February 2015, all 63 patients admitted to the ICU were screened for rectal CRAB colonisation upon admission and once weekly thereafter. ICU patients who acquired a CRAB nosocomial infection were also included. β-Lactamases and associated resistance genes were screened by PCR sequencing, and molecular typing was performed by PFGE and MLST. The CRAB faecal carriage rate at admission was 4.8% (3/63). The CRAB acquisition rate during ICU stay was analysed in 39 of the remaining 60 patients and the rate of acquired CRAB faecal carriage was 15.4% (6/39); 4 patients also showed an ICU-acquired CRAB infection (one patient was a faecal carrier and suffered infection). Overall, 13 CRAB isolates were collected from 12 patients, of which 11 isolates showed resistance to all antibiotics tested except colistin. blaOXA-23 and blaNDM-1 were detected in 11 and 2 isolates, respectively. All OXA-23-producing strains carried armA, tetB, sul1 and catB, and some of them carried aph(3′)-VIa, blaTEM-1, aph(3′)-Ia and ant(2′′)-Ia. The blaNDM-1-positive isolates harboured aph(3′)-VIa and catB. Three PFGE patterns and two STs were identified [ST195 (n = 11), ST1089 (n = 2, NDM-1-positive)]. Whether imported or acquired during ICU stay, CRAB colonisation is a major risk factor for the occurrence of serious nosocomial infection. Systematic screening of faecal carriage is mandatory to prevent their spread.</description><identifier>ISSN: 0924-8579</identifier><identifier>EISSN: 1872-7913</identifier><identifier>DOI: 10.1016/j.ijantimicag.2018.04.008</identifier><identifier>PMID: 29665444</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Acinetobacter baumannii ; arbapenemase ; Gastrointestinal colonisation ; ICU</subject><ispartof>International journal of antimicrobial agents, 2018-12, Vol.52 (6), p.910-915</ispartof><rights>2018 Elsevier B.V. and International Society of Chemotherapy</rights><rights>Copyright © 2018 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c377t-252c9c3e3517fc502c0d0c37fa201d2e0b56b144dfbbaafa3f1949ffc1efb68c3</citedby><cites>FETCH-LOGICAL-c377t-252c9c3e3517fc502c0d0c37fa201d2e0b56b144dfbbaafa3f1949ffc1efb68c3</cites><orcidid>0000-0003-3709-1690 ; 0000-0003-0241-2191</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0924857918301109$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29665444$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Maamar, Elaa</creatorcontrib><creatorcontrib>Alonso, Carla Andrea</creatorcontrib><creatorcontrib>Ferjani, Sana</creatorcontrib><creatorcontrib>Jendoubi, Ali</creatorcontrib><creatorcontrib>Hamzaoui, Zaineb</creatorcontrib><creatorcontrib>Jebri, Alia</creatorcontrib><creatorcontrib>Saidani, Mabrouka</creatorcontrib><creatorcontrib>Ghedira, Salma</creatorcontrib><creatorcontrib>Torres, Carmen</creatorcontrib><creatorcontrib>Boubaker, Ilhem Boutiba-Ben</creatorcontrib><title>NDM-1- and OXA-23-producing Acinetobacter baumannii isolated from intensive care unit patients in Tunisia</title><title>International journal of antimicrobial agents</title><addtitle>Int J Antimicrob Agents</addtitle><description>•High prevalence of imported/acquired carbapenem-resistant A. baumannii (CRAB) faecal carriage among ICU patients.•OXA-23 was the most frequent carbapenemase among identified CRAB, followed by NDM-1.•Co-occurrence of carbapenem and aminoglycoside resistance genes among multidrug-resistant A. baumannii.•Circulation of clonally related CRAB strains. Gastrointestinal colonisation by carbapenem-resistant Acinetobacter baumannii (CRAB) is a critical step before nosocomial infection. This study evaluated CRAB intestinal carriage in patients admitted to a Tunisian ICU and determined the antimicrobial resistance mechanisms involved. From December 2014 to February 2015, all 63 patients admitted to the ICU were screened for rectal CRAB colonisation upon admission and once weekly thereafter. ICU patients who acquired a CRAB nosocomial infection were also included. β-Lactamases and associated resistance genes were screened by PCR sequencing, and molecular typing was performed by PFGE and MLST. The CRAB faecal carriage rate at admission was 4.8% (3/63). The CRAB acquisition rate during ICU stay was analysed in 39 of the remaining 60 patients and the rate of acquired CRAB faecal carriage was 15.4% (6/39); 4 patients also showed an ICU-acquired CRAB infection (one patient was a faecal carrier and suffered infection). Overall, 13 CRAB isolates were collected from 12 patients, of which 11 isolates showed resistance to all antibiotics tested except colistin. blaOXA-23 and blaNDM-1 were detected in 11 and 2 isolates, respectively. All OXA-23-producing strains carried armA, tetB, sul1 and catB, and some of them carried aph(3′)-VIa, blaTEM-1, aph(3′)-Ia and ant(2′′)-Ia. The blaNDM-1-positive isolates harboured aph(3′)-VIa and catB. Three PFGE patterns and two STs were identified [ST195 (n = 11), ST1089 (n = 2, NDM-1-positive)]. Whether imported or acquired during ICU stay, CRAB colonisation is a major risk factor for the occurrence of serious nosocomial infection. Systematic screening of faecal carriage is mandatory to prevent their spread.</description><subject>Acinetobacter baumannii</subject><subject>arbapenemase</subject><subject>Gastrointestinal colonisation</subject><subject>ICU</subject><issn>0924-8579</issn><issn>1872-7913</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNqNkE9vFDEMxSNERbeFr4DCjUsGJ5P5d1wttFQq7aVI3KJMxqm82sksSaYS355UWxBHLrZkP_vp_Rj7IKGSINtP-4r2NmSaydnHSoHsK9AVQP-KbWTfKdENsn7NNjAoLfqmG87ZRUp7ANnUunnDztXQto3WesPo7vM3IQW3YeL3P7ZC1eIYl2l1FB75tlTMy2hdxshHu842BCJOaTnYjBP3cZk5hYwh0RNyZyPyNVDmR5sJQ05lyR_KJJF9y868PSR899Iv2ferLw-7r-L2_vpmt70Vru66LFSj3OBqrBvZedeAcjBBWXlbck4KYWzaUWo9-XG01tvay0EP3juJfmx7V1-yj6e_JcfPFVM2MyWHh4MNuKzJKFAddND2fZEOJ6mLS0oRvTlGmm38ZSSYZ9Jmb_4hbZ5JG9CmkC63719s1nHG6e_lH7RFsDsJsIR9IowmucLE4UQRXTbTQv9h8xuwN5Zc</recordid><startdate>201812</startdate><enddate>201812</enddate><creator>Maamar, Elaa</creator><creator>Alonso, Carla Andrea</creator><creator>Ferjani, Sana</creator><creator>Jendoubi, Ali</creator><creator>Hamzaoui, Zaineb</creator><creator>Jebri, Alia</creator><creator>Saidani, Mabrouka</creator><creator>Ghedira, Salma</creator><creator>Torres, Carmen</creator><creator>Boubaker, Ilhem Boutiba-Ben</creator><general>Elsevier B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-3709-1690</orcidid><orcidid>https://orcid.org/0000-0003-0241-2191</orcidid></search><sort><creationdate>201812</creationdate><title>NDM-1- and OXA-23-producing Acinetobacter baumannii isolated from intensive care unit patients in Tunisia</title><author>Maamar, Elaa ; Alonso, Carla Andrea ; Ferjani, Sana ; Jendoubi, Ali ; Hamzaoui, Zaineb ; Jebri, Alia ; Saidani, Mabrouka ; Ghedira, Salma ; Torres, Carmen ; Boubaker, Ilhem Boutiba-Ben</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c377t-252c9c3e3517fc502c0d0c37fa201d2e0b56b144dfbbaafa3f1949ffc1efb68c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Acinetobacter baumannii</topic><topic>arbapenemase</topic><topic>Gastrointestinal colonisation</topic><topic>ICU</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Maamar, Elaa</creatorcontrib><creatorcontrib>Alonso, Carla Andrea</creatorcontrib><creatorcontrib>Ferjani, Sana</creatorcontrib><creatorcontrib>Jendoubi, Ali</creatorcontrib><creatorcontrib>Hamzaoui, Zaineb</creatorcontrib><creatorcontrib>Jebri, Alia</creatorcontrib><creatorcontrib>Saidani, Mabrouka</creatorcontrib><creatorcontrib>Ghedira, Salma</creatorcontrib><creatorcontrib>Torres, Carmen</creatorcontrib><creatorcontrib>Boubaker, Ilhem Boutiba-Ben</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of antimicrobial agents</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Maamar, Elaa</au><au>Alonso, Carla Andrea</au><au>Ferjani, Sana</au><au>Jendoubi, Ali</au><au>Hamzaoui, Zaineb</au><au>Jebri, Alia</au><au>Saidani, Mabrouka</au><au>Ghedira, Salma</au><au>Torres, Carmen</au><au>Boubaker, Ilhem Boutiba-Ben</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>NDM-1- and OXA-23-producing Acinetobacter baumannii isolated from intensive care unit patients in Tunisia</atitle><jtitle>International journal of antimicrobial agents</jtitle><addtitle>Int J Antimicrob Agents</addtitle><date>2018-12</date><risdate>2018</risdate><volume>52</volume><issue>6</issue><spage>910</spage><epage>915</epage><pages>910-915</pages><issn>0924-8579</issn><eissn>1872-7913</eissn><abstract>•High prevalence of imported/acquired carbapenem-resistant A. baumannii (CRAB) faecal carriage among ICU patients.•OXA-23 was the most frequent carbapenemase among identified CRAB, followed by NDM-1.•Co-occurrence of carbapenem and aminoglycoside resistance genes among multidrug-resistant A. baumannii.•Circulation of clonally related CRAB strains. Gastrointestinal colonisation by carbapenem-resistant Acinetobacter baumannii (CRAB) is a critical step before nosocomial infection. This study evaluated CRAB intestinal carriage in patients admitted to a Tunisian ICU and determined the antimicrobial resistance mechanisms involved. From December 2014 to February 2015, all 63 patients admitted to the ICU were screened for rectal CRAB colonisation upon admission and once weekly thereafter. ICU patients who acquired a CRAB nosocomial infection were also included. β-Lactamases and associated resistance genes were screened by PCR sequencing, and molecular typing was performed by PFGE and MLST. The CRAB faecal carriage rate at admission was 4.8% (3/63). The CRAB acquisition rate during ICU stay was analysed in 39 of the remaining 60 patients and the rate of acquired CRAB faecal carriage was 15.4% (6/39); 4 patients also showed an ICU-acquired CRAB infection (one patient was a faecal carrier and suffered infection). Overall, 13 CRAB isolates were collected from 12 patients, of which 11 isolates showed resistance to all antibiotics tested except colistin. blaOXA-23 and blaNDM-1 were detected in 11 and 2 isolates, respectively. All OXA-23-producing strains carried armA, tetB, sul1 and catB, and some of them carried aph(3′)-VIa, blaTEM-1, aph(3′)-Ia and ant(2′′)-Ia. The blaNDM-1-positive isolates harboured aph(3′)-VIa and catB. Three PFGE patterns and two STs were identified [ST195 (n = 11), ST1089 (n = 2, NDM-1-positive)]. Whether imported or acquired during ICU stay, CRAB colonisation is a major risk factor for the occurrence of serious nosocomial infection. Systematic screening of faecal carriage is mandatory to prevent their spread.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>29665444</pmid><doi>10.1016/j.ijantimicag.2018.04.008</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0003-3709-1690</orcidid><orcidid>https://orcid.org/0000-0003-0241-2191</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0924-8579
ispartof International journal of antimicrobial agents, 2018-12, Vol.52 (6), p.910-915
issn 0924-8579
1872-7913
language eng
recordid cdi_proquest_miscellaneous_2027070688
source Elsevier ScienceDirect Journals
subjects Acinetobacter baumannii
arbapenemase
Gastrointestinal colonisation
ICU
title NDM-1- and OXA-23-producing Acinetobacter baumannii isolated from intensive care unit patients in Tunisia
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-19T13%3A04%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=NDM-1-%20and%20OXA-23-producing%20Acinetobacter%20baumannii%20isolated%20from%20intensive%20care%20unit%20patients%20in%20Tunisia&rft.jtitle=International%20journal%20of%20antimicrobial%20agents&rft.au=Maamar,%20Elaa&rft.date=2018-12&rft.volume=52&rft.issue=6&rft.spage=910&rft.epage=915&rft.pages=910-915&rft.issn=0924-8579&rft.eissn=1872-7913&rft_id=info:doi/10.1016/j.ijantimicag.2018.04.008&rft_dat=%3Cproquest_cross%3E2027070688%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2027070688&rft_id=info:pmid/29665444&rft_els_id=S0924857918301109&rfr_iscdi=true